Application of new cholesterol guidelines to a population-based sample.
about
Multimodality Imaging in Coronary Artery Disease: Focus on Computed TomographyDyslipidemia management in primary prevention of cardiovascular disease: Current guidelines and strategiesPrimary Biliary Cirrhosis and Primary Sclerosing Cholangitis: a Review Featuring a Women's Health PerspectiveUse of statins and the incidence of type 2 diabetes mellitusStatins: Cholesterol guidelines and Indian perspectiveIs immunity a mechanism contributing to statin-induced diabetes?Implementation of the 2013 American College of Cardiology/American Heart Association Blood Cholesterol Guideline Including Data From the Improved Reduction of Outcomes: Vytorin Efficacy International TrialStatins, cognition, and dementia—systematic review and methodological commentaryPathways Forward in Cardiovascular Disease Prevention One and a Half Years After Publication of the 2013 ACC/AHA Cardiovascular Disease Prevention GuidelinesNon-cardiovascular effects associated with statinsStatin-Induced Increases in Atrophy Gene Expression Occur Independently of Changes in PGC1α Protein and Mitochondrial ContentOverview of guidelines for the management of dyslipidemia: EU perspectivesCurrent and Emerging Uses of Statins in Clinical Therapeutics: A ReviewThe use of expensive technologies instead of simple, sound and effective lifestyle interventions: a perpetual delusionHeart Disease and Stroke Statistics-2017 Update: A Report From the American Heart AssociationStatins in Primary Prevention: Uncertainties and Gaps in Randomized Trial Data.The Cost-Benefit Balance of Statins in Hawai'i: A Moving Target.Statin Therapy Prescribing for Patients with Type 2 Diabetes Mellitus: A Review of Current Evidence and Challenges.Caveolin contributes to the modulation of basal and β-adrenoceptor stimulated function of the adult rat ventricular myocyte by simvastatin: a novel pleiotropic effectAtherosclerotic cardiovascular disease prevention: a comparison between the third adult treatment panel and the new 2013 Treatment of Blood Cholesterol Guidelines.Real-life evaluation of European and American high-risk strategies for primary prevention of cardiovascular disease in patients with first myocardial infarction.Hypertension in the United States, 1999 to 2012: progress toward Healthy People 2020 goals.Improving medication adherence in hypercholesterolemia: challenges and solutions.Does use of pooled cohort risk score overestimate the use of statin?: a retrospective cohort study in a primary care settingStatinopause.Validation of the pooled cohort risk score in an Asian population - a retrospective cohort study.Impact of the New ACC/AHA Guidelines on the Treatment of High Blood Cholesterol in a Managed Care Setting.HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials.Is there a clinically relevant interaction between clarithromycin and statins not metabolized by cytochrome P450 3A4?Implications of the new American College of Cardiology/American Heart Association cholesterol guidelines for primary atherosclerotic cardiovascular disease event prevention in a multi ethnic cohort: Multi-Ethnic Study of Atherosclerosis (MESA)Statins increase the frequency of circulating CD4+ FOXP3+ regulatory T cells in healthy individuals.Hyperlipidemia in early adulthood increases long-term risk of coronary heart disease.Does diagnosing fatty liver and chronic kidney disease do more good than harm?A mathematical model of atherosclerosis with reverse cholesterol transport and associated risk factors.Statins, plasma cholesterol, and risk of Parkinson's disease: a prospective study2013 American College of Cardiology/American Heart Association and 2004 Adult Treatment Panel III cholesterol guidelines applied to HIV-infected patients with/without subclinical high-risk coronary plaque.Contrasting Cholesterol Management Guidelines for Adults with CKD.The growing gap in hypertension control between insured and uninsured adults: National Health and Nutrition Examination Survey 1988 to 2010Evidence-based deprescribing of statins in patients with advanced illness.Interaction analysis of the new pooled cohort equations for 10-year atherosclerotic cardiovascular disease risk estimation: a simulation analysis.
P2860
Q26747757-315059D5-7223-4972-93B7-CF8DEA38ADFDQ26765157-CE4A919A-518D-44BB-B5C9-0ABFFB63F507Q26781780-FD249425-3999-42FD-9874-1E17098214CDQ26783136-A3DB2733-24AB-4462-BBBD-09C867DC26B7Q26783226-97D4B713-6A90-440C-822F-ECC13178720CQ26785561-0B129B5C-EDB3-47BB-AF05-3957A00D625BQ26801245-C156BAAF-2C0C-4312-8587-544BB6CB6A7FQ26852778-084593A8-37EE-4D4B-8A56-B8B6985E4A66Q26991787-E857CC24-C039-41A2-BA64-F7E0ADA83C0EQ27026332-8052D795-F493-4161-8D02-02CE245AC5C5Q27305332-AE56456B-65AC-4C9F-9F63-162DAE335AECQ28069411-96CAF0E0-2917-47D4-8B51-0B6D8EF18552Q28076346-60C0D8D4-284C-4A31-90CD-6D3005CE6127Q28654209-FC07822A-D3D6-4F84-95E5-13F17FEE69C7Q30238784-72FF7599-F274-4FE6-80A8-D494F22F3FB3Q31133434-715A8655-78F4-4084-87F8-29A2109683EAQ33576140-157A15F5-8BBF-4A6E-8572-73824612094BQ33900403-CBD52AE8-4767-4FF2-B7EC-5DC11BB4CB67Q34166022-348C51AC-E204-4242-AA90-D1B8CCB57A9DQ34207126-C228D0D0-246B-41D8-9128-B586962D05EAQ34364949-4B6519CC-AFB9-45BA-8C55-1AC7CE98BC0BQ34459136-573E0E50-9B7C-47E7-82EE-32A5F80E9A96Q34482456-9E67DD6C-7A86-4118-8728-5FE13AACDAB4Q34537368-4894A82F-6018-4ADF-8347-21F455E94D4EQ34566869-A49B50A9-9C95-4698-8BF1-A87808438B4AQ34582520-748E51B0-C8EB-477E-94CB-1044E26A31CBQ34792459-67384619-3F65-4766-82B1-AD9B0AD74374Q35065253-E76714AB-1E24-460C-828F-5FC51FCC3DE6Q35088411-F8967248-B62C-4969-B62F-BF6EFCCB0FBCQ35142002-0DF0ECBD-4537-496C-BFDA-D5A18EB8AAE3Q35156091-E390BE56-031E-46E4-A4D9-3F616E5814E4Q35207627-61C63DD8-83A7-4203-B5BB-AA344D43C56FQ35210916-FCBF489F-3C06-4A49-9FB4-C2C176F6E6D7Q35245132-FDC18A8D-8F1C-4CC5-B7F8-D1FCC3AF61DCQ35328089-97109E1B-127C-4367-883E-A12EE80A3830Q35510401-C16D60A4-701A-41B8-8784-39BE859A1CBFQ35550614-C1EFF479-243D-4D39-91D8-D4BB56BC8D81Q35551467-680124A1-E8FD-47D2-BFEC-54F65F31BDD3Q35572237-01168AB1-7254-4C85-B080-940DB0D21385Q35573159-0642C97C-C6C0-497E-B4CA-5AD81FB3AA53
P2860
Application of new cholesterol guidelines to a population-based sample.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Application of new cholesterol guidelines to a population-based sample.
@en
Application of new cholesterol guidelines to a population-based sample.
@nl
type
label
Application of new cholesterol guidelines to a population-based sample.
@en
Application of new cholesterol guidelines to a population-based sample.
@nl
prefLabel
Application of new cholesterol guidelines to a population-based sample.
@en
Application of new cholesterol guidelines to a population-based sample.
@nl
P2093
P356
P1476
Application of new cholesterol guidelines to a population-based sample.
@en
P2093
Allan D Sniderman
Benjamin Neely
Ken Williams
Michael J Pencina
Ralph B D'Agostino
P304
P356
10.1056/NEJMOA1315665
P407
P577
2014-03-19T00:00:00Z